Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Feb 6;7(1):162-70.
doi: 10.4292/wjgpt.v7.i1.162.

Economic evaluations in gastroenterology in Brazil: A systematic review

Luciana Bertocco de Paiva Haddad  1 , Tassia Cristina Decimoni  1 , Jose Antonio Turri  1 , Roseli Leandro  1 , Patrícia Coelho de Soárez  1
Affiliations

Economic evaluations in gastroenterology in Brazil: A systematic review

Luciana Bertocco de Paiva Haddad et al. World J Gastrointest Pharmacol Ther. .

Abstract

Aim: To systematically review economic evaluations in gastroenterology, relating to Brazil, published between 1980 and 2013.

Methods: We selected full and partial economic evaluations from among those retrieved by searching the following databases: MEDLINE (PubMed); Excerpta Medica; the Latin American and Caribbean Health Sciences Literature database; the Scientific Electronic Library Online; the database of the Centre for Reviews and Dissemination; the National Health Service (NHS) Economic Evaluation Database; the NHS Health Technology Assessment database; the Health Economics database of the Brazilian Virtual Library of Health; Scopus; Web of Science; and the Brazilian Network for the Evaluation of Health Technologies. Two researchers, working independently, selected the studies and extracted the data.

Results: We identified 535 health economic evaluations relating to Brazil and published in the 1980-2013 period. Of those 535 articles, only 40 dealt with gastroenterology. Full and partial economic evaluations respectively accounted for 23 (57.5%) and 17 (42.5%) of the 40 studies included. Among the 23 full economic evaluations, there were 11 cost-utility analyses, seven cost-effectiveness analyses, four cost-consequence analyses, and one cost-minimization analysis. Of the 40 studies, 25 (62.5%) evaluated medications; 7 (17.5%) evaluated procedures; and 3 (7.5%) evaluated equipment. Most (55%) of the studies were related to viral hepatitis, and most (63.4%) were published after 2010. Other topics included gastrointestinal cancer, liver transplantation, digestive diseases and hernias. Over the 33-year period examined, the number of such economic evaluations relating to Brazil, especially of those evaluating medications for the treatment of hepatitis, increased considerably.

Conclusion: Further studies are needed in order to ensure that expenditures on health care in Brazil are made as fairly and efficiently as possible.

Keywords: Brazil; Cost-benefit analysis; Costs and cost analysis; Gastroenterology; Health care costs.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow diagram of the process for the selection of economic evaluations in gastroenterology related to Brazil, 1980-2013. EMBASE: Excerpta Medica; LILACS: Latin American and Caribbean Health Sciences Literature; SciELO: Scientific Electronic Library Online; NHS EED: (United Kingdom) National Health Service Economic Evaluation Database; HTA: Health Technology Assessment; BVS ECOS: Biblioteca Virtual em Saúde Economia da Saúde [Health Economics (database) of the (Brazilian) Virtual Library of Health]; Bireme: Biblioteca Regional de Medicina (Regional Library of Medicine); JBES: Jornal Brasileiro de Economia da Saúde (Brazilian Journal of Health Economics); SISREBRATS: Sistema de Informação da Rede Brasileira de Avaliação de Tecnologias em Saúde (Brazilian Network for the Evaluation of Health Technologies); EES: Economic evaluation study.
Figure 2
Figure 2
Number of economic evaluations in gastroenterology related to Brazil, by type, 1982-2013. CUA: Cost-utility analysis; CCA: Cost-consequence analysis; CEA: Cost-effectiveness analysis; CMA: Cost-minimization analysis; CD: Cost description; CA: Cost analysis; COD: Cost-outcome description.
Figure 3
Figure 3
Number and proportional distribution of economic evaluations in gastroenterology related to Brazil, by publication date and theme, 1982-2013.
Figure 4
Figure 4
Means and standard deviations for Journal Citation Report impact factors among economic evaluations in gastroenterology related to Brazil, by year of publication, 2000-2013.
See this image and copyright information in PMC

References

    1. Drummond MF. Economic evaluation of treatment strategies in gastroenterology. Am J Gastroenterol. 2005;100:2143–2145. - PubMed
    1. Augustovski F, Iglesias C, Manca A, Drummond M, Rubinstein A, Martí SG. Barriers to generalizability of health economic evaluations in Latin America and the Caribbean region. Pharmacoeconomics. 2009;27:919–929. - PubMed
    1. Kleinman L, McIntosh E, Ryan M, Schmier J, Crawley J, Locke GR, De Lissovoy G. Willingness to pay for complete symptom relief of gastroesophageal reflux disease. Arch Intern Med. 2002;162:1361–1366. - PubMed
    1. Ladabaum U, Fendrick AM, Glidden D, Scheiman JM. Helicobacter pylori test-and-treat intervention compared to usual care in primary care patients with suspected peptic ulcer disease in the United States. Am J Gastroenterol. 2002;97:3007–3014. - PubMed
    1. Ford AC, Delaney BC, Forman D, Moayyedi P. Eradication therapy in Helicobacter pylori positive peptic ulcer disease: systematic review and economic analysis. Am J Gastroenterol. 2004;99:1833–1855. - PubMed

LinkOut - more resources